Evidence map›Paper›PMID 29118205›Full record

ReviewThe Journal of neuroscience : the official journal of the Society for Neuroscience2017

Epigenetic Etiology of Intellectual Disability.

Shigeki Iwase, Nathalie G Bérubé, Zhaolan Zhou, Nael Nadif Kasri, Elena Battaglioli, Marilyn Scandaglia, Angel Barco

Open access · bronzeAbstract readReview
In one paragraph

Review in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 70 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
70citing papers in PubMed, 1 pooled it
9.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

70 citing papers in PubMed, 1 synthesis or guideline pooled it, 131 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Review
  6. Article
  7. Shared and distinct phenotypic profiles among neurodevelopmental disorder genes.medRxiv : the preprint server for health sciences · 2026
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

10 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 6 institutions in 5 countries.

Shigeki IwaseUniversity of Michigan Medical School, Medical Science II, Ann Arbor, Michigan 48109-5618.ORCID 0000-0003-2280-7422
Nathalie G BérubéWestern University and Children's Health Research Institute, Victoria Research Laboratories, London, Ontario N6C 2V5, Canada.ORCID 0000-0003-1948-8715
Zhaolan ZhouDepartment of Genetics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania 19104-6145.
Nael Nadif KasriDonders Institute for Brain, Cognition and Behaviour, Radboud University Medical Centre, 6500 HB, Nijmegen, The Netherlands.ORCID 0000-0002-7448-9289
Elena BattaglioliUniversity of Milan, Department Medical Biotechnology and Translational Medicine, 20090 Segrate (MI), Italy, and.
Marilyn ScandagliaInstituto de Neurociencias, Molecular Neurobiology Unit, s/n 03550, San Juan de Alicante, Alicante, Spain.
Angel BarcoInstituto de Neurociencias, Molecular Neurobiology Unit, s/n 03550, San Juan de Alicante, Alicante, Spain abarco@umh.es.ORCID 0000-0002-0653-3751
Instituto de Neurociencias · ESRadboud University Nijmegen · NLUniversity of Michigan · USUniversity of Milan · ITUniversity of Pennsylvania · USWestern University · CA

Funding

Understanding the Pathogenic Mechanisms of Rett SyndromeR01NS081054 · NINDS · UNIVERSITY OF PENNSYLVANIA · PI Zhaolan Zhou · 2013 to 2026
$5.6M
Defining the Epigenetic Architecture Associated with Early-Life StressR01MH091850 · NIMH · UNIVERSITY OF PENNSYLVANIA · PI ZHOU, ZHAOLAN · 2010 to 2014
$2.4M
Neutralizing epigenomes in neurodevelopment disordersR01NS089896 · NINDS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI IWASE, SHIGEKI · 2015 to 2019
$2.1M
CIHR MOP 142268NIMH NIH HHS R01 MH091850NINDS NIH HHS R01 NS081054NINDS NIH HHS R01 NS089896
6 · The paper itself

Abstract

Intellectual disability (ID) is a prevailing neurodevelopmental condition associated with impaired cognitive and adaptive behaviors. Many chromatin-modifying enzymes and other epigenetic regulators have been genetically associated with ID disorders (IDDs). Here we review how alterations in the function of histone modifiers, chromatin remodelers, and methyl-DNA binding proteins contribute to neurodevelopmental defects and altered brain plasticity. We also discuss how progress in human genetics has led to the generation of mouse models that unveil the molecular etiology of ID, and outline the direction in which this field is moving to identify therapeutic strategies for IDDs. Importantly, because the chromatin regulators linked to IDDs often target common downstream genes and cellular processes, the impact of research in individual syndromes goes well beyond each syndrome and can also contribute to the understanding and therapy of other IDDs. Furthermore, the investigation of these disorders helps us to understand the role of chromatin regulators in brain development, plasticity, and gene expression, thereby answering fundamental questions in neurobiology.

Indexed as

Epigenesis, GeneticEpigenomicsHumansIntellectual DisabilityClaes-Jensen syndromeDNA methylationhistone posttranslational modificationKleefstra syndromeneuroepigeneticsRett syndromeRubinstein-Taybi syndromeX-linked intellectual disabilityα-thalassemia mental retardation syndrome

Identifiers

PMID29118205
PMCPMC5678009
OpenAlexW2786179447

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.